Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

127 recalls · Class I, newest first

Class I · High risk

TruTrim (product not labeled)

Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid in dietary supplements.

Terminated Unapproved drug Novacare, LLC D-0967-2016
Class I · High risk

Prolotherapy with Phenol

Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Terminated Sterility / contamination Hartley Medical Center Pharmacy, Incorporated D-1830-2015
Class I · High risk

Prolotherapy with Phenol

Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.

Terminated Sterility / contamination Hartley Medical Center Pharmacy, Incorporated D-1829-2015
Class I · High risk

LiDa DAIDAIHUA

Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.

Terminated Chemical / undeclared Blue Square Market, Inc. D-0296-2016
Class I · High risk

fentaNYL Citrate

Subpotent Drug: confirmed subpotency in one lot of this product that was packaged and stored in syringes.

Terminated Wrong potency / content Pharmedium Services, LLC D-0093-2017

Recalls by year